Veverka KA, Thng STG, Silverberg JI, Armstrong AW, et al. Safety and efficacy of eblasakimab, an IL-13Ralpha1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: a phase 1b, multiple-ascending dose study. J Am Acad Dermatol 2023 Oct 20:S0190-9622(23)03029.
PMID: 37866456